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DOI 10.1016/j.ccr.2009.11.024SUMMARYTransplantation studies have demonstrated the existence ofmammary progenitor cells with the ability to self-
renew and regenerate a functional mammary gland. Although these progenitors are the likely targets for
oncogenic transformation, correlating progenitor populations with certain oncogenic stimuli has been diffi-
cult. Cyclin D1 is required for lobuloalveolar development during pregnancy and lactation as well as
MMTV-ErbB2- but not MMTV-Wnt1-mediated tumorigenesis. Using a kinase-deficient cyclin D1 mouse,
we identified two functional mammary progenitor cell populations, one of which is the target of MMTV-
ErbB2. Moreover, cyclin D1 activity is required for the self-renewal and differentiation of mammary progen-
itors because its abrogation leads to a failure to maintain the mammary epithelial regenerative potential and
also results in defects in luminal lineage differentiation.INTRODUCTION
Breast cancer is a heterogeneous disease. Using gene expres-
sion profiling analysis, human breast cancers and mouse
mammary tumor models have been broadly classified into either
luminal-like or basal-like cancers (Perou et al., 2000). For
example, theMMTV-Wnt1 tumor model has been shown to clas-
sify with human basal-like breast cancers, a fact very much in
keeping with the observed association of Wnt signaling in human
basal-like mammary tumors (DiMeo et al., 2009; Herschkowitz
et al., 2007), whereas the MMTV-ErbB2 tumor model has been
shown to classify with human luminal-type breast cancers
(Herschkowitz et al., 2007). Although it is presumed that these
different tumor subtypes originate from different epithelial
targets, the identity of these target cells is unclear.
Themammary gland is composed of a heterogeneous popula-
tion of cells ranging from terminally differentiated cells with
limited proliferative potential to multipotent stem and progenitor
cells with extensive proliferative, differentiative, and self-renewalSIGNIFICANCE
The cellular origins of breast-cancer-initiating cells have remain
into basal and luminal types based on protein and gene exp
cancers might arise from different target populations of breas
cell populations with different hormonal sensitivities and requi
that the cellular origins of certain types of breast cancer may h
tumor subtypes may offer therapeutic targets in human breascapacities. Two main epithelial cell types are found in the virgin
mammary tissue: luminal cells that line the lumens and express
hormone receptors, and myoepithelial cells that are localized
at the interface between luminal cells and the basement
membrane and have specialized contractile functions. A third
secretory or alveolar cell type arises during pregnancy within
the terminal ductal lobular units but undergoes programmed
cell death following the cessation of lactation.
An important and underappreciated feature of mammary
tissues is the fact that they are composed of ducts and lobules,
which are anatomically distinct structures with fundamentally
different functions. Ducts are bifurcated linear structures that
direct the flow of milk out of the gland whereas lobules are lateral
side branching structures terminating in acinar pouchings that
become alveoli during pregnancy. Consistent with this anatom-
ical organization is the existence of multipotent progenitor cells
that can be distinguished by their ability to produce lobule-
limited, ductal-limited, or complete mammary outgrowths
following transplantation (Kordon and Smith, 1998). All threeed obscure. In addition, the heterogeneity of breast cancers
ression patterns suggests that different subtypes of breast
t epithelial cells. Identification of distinct stem or progenitor
rements for cyclin D1 activity is appealing because it implies
ave a similar specificity. These specific requirements among
t tumors.
Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc. 65
Figure 1. PI-MECs Are Reduced in Cyclin D1KE/KE Mice and Are the Targets of MMTV-ErbB2-Mediated Transformation
(A) Tumor-free curve of multiparous (three rounds of pregnancy and involution) cyclin D1+/+/MMTV-ErbB2 and cyclin D1KE/KE/MMTV-ErbB2 females.
(B) Flow cytometry analysis for CD24 and Sca surface markers showing a decrease in the CD24+Sca1+ population (24H, Sca+) in cyclin D1KE/KE/MMTV-ErbB2
MECs compared with cyclin D1+/+/MMTV-ErbB2 littermates. Error bars indicate mean and standard deviation (± SD); *p < 0.001.
(C) As shown in the upper panels: Flow cytometry analysis for the detection of GFP-positive cells in virgin and lactating cyclin D1+/+/MMTV-ErbB2/Wap-Cre/
Rosa-GFP mammary glands (cyclin D1+/+: nulliparous, lactation) as well as virgin and lactating cyclin D1KE/KE /MMTV-ErbB2/Wap-Cre/Rosa-GFP (cyclin
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Cyclin D1 Regulates Mammary Progenitorscell types are thought to arise from a common precursor, but the
precise cell types that generate ductal- or lobule-limited
outgrowths have not been identified.
Several reports have described the identification of multipo-
tent progenitor cells that exhibit self-renewal properties and
can contribute to ductal, lobular, and alveolar morphogenesis
(Booth et al., 2007). One type of stem/progenitor cell can be
identified on the basis of a CD24MedCD29Hi or CD24+CD49fHi
cell surface phenotype (Shackleton et al., 2006; Stingl et al.,
2006). However, a second type of progenitor cell has been re-
ported that is capable of establishing a fully functional mammary
gland upon transplantation at limiting dilution, and is able to
generate all the diverse epithelial lineages present in the murine
mammary tissue (Boulanger et al., 2005; Henry et al., 2004;
Smith and Medina, 2008; Wagner et al., 2002). These progenitor
cells, termed parity-identified mammary epithelial cells (PI-
MECs), are present in both nulliparous and parous glands, and
can also give rise to lobule-limited structures (Smith andMedina,
2008). At present, the link between PI-MEC progenitor cells and
CD24MedCD29Hi or CD24+CD49fHi populations is unclear. In
addition, it has been assumed that mammary stem/progenitor
cells are the targets for oncogenic transformation, but identifying
which progenitor population is the target for which oncogenic
stimulus has been difficult.
Cyclin D1 is a critical component of the cell cycle that is
required for mammary gland development. Cyclin D1-knockout
mice fail to generate lobuloalveoli during pregnancy and cannot
lactate (Fantl et al., 1995; Sicinski et al., 1995). Interestingly, cy-
clin D1 knockout mice are resistant to MMTV-ErbB2-mediated
tumorigenesis, a fact very much in keeping with the observed
overexpression of cyclin D1 in the majority of human luminal
mammary tumors (Gauthier et al., 2007; Yu et al., 2001). In
contrast, cyclin D1 knockout mice are still susceptible to
MMTV-Wnt1-mediated oncogenesis, suggesting the possibility
that these tumors originate from different epithelial targets that
exhibit different sensitivities to cyclin D1 expression.
In order to dissect the roles of cyclin D1-associated kinase
activity during mammary gland development andMMTV-ErbB2-
induced tumorigenesis, we have generated the point mutant
cyclin D1 (K112E) knockin mouse. The cyclin D1-K112E protein
can still bind to cyclin-dependent kinases 4 and 6 (Cdk4/6) but
the resulting complexes are enzymatically inactive (Baker
et al., 2005; Hinds et al., 1994). We have previously shown that
cyclin D1KE/KE female mice displayed apparently developed
lobuloalveoli following pregnancy, yet they remained protected
against the development of MMTV-ErbB2-driven mammary
tumors (Landis et al., 2006). In the current study, we sought to
determine the cellular mechanisms by which the absence of
cyclin D1-associated kinase activity does not seem to affectD1KE/KE: nulliparous, lactation). As shown in the lower panels and graph: Flow c
D1+/+/MMTV-ErbB2/Wap-Cre/Rosa-GFP (cyclin D1+/+) and cyclin D1KE/KE/MMTV
lactational involution. Error bars indicate mean ± SD; *p < 0.001.
(D) The expansion of theGFP-positive cells was detected by flow cytometry analys
ErbB2/Wap-Cre/Rosa-GFP mammary gland with early hyperplastic lesions (hyp
pregnant cyclin D1+/+/MMTV-ErbB2/Wap-Cre/Rosa-GFP mouse revealing GFP
bar represents 100 mm. As shown in (b), hematoxylin and eosin (H&E)-stained se
represent early hyperplastic lesions. The lymph node (LN) is GFP negative. The s
lesion. The scale bar represents 50 mm.development but can block the formation of ErbB2-driven
mammary tumors.
RESULTS
PI-MEC Progenitor Cells Are the Targets of MMTV-
ErbB2-Mediated Tumorigenesis and Cannot Be
Maintained in Cyclin D1KE/KE Mutant Mice
We have previously reported that nulliparous mice deficient in
cyclin D1 kinase activity failed to develop mammary tumors on
anMMTV-ErbB2 background despite exhibiting normal lobuloal-
veolar development after a single round of pregnancy and lacta-
tion (Landis et al., 2006). However, it has been well established
that the development of MMTV-ErbB2-driven mammary tumors
can be accelerated following repeated cycles of pregnancy
(Henry et al., 2004). Therefore, we first sought to determine
whether multiple pregnancies in cyclin D1KE/KE mice might over-
come their tumor resistance. We found that after three rounds of
consecutive breeding cycles, cyclin D1KE/KE/MMTV-ErbB2 mice
remained resistant to the development of mammary tumors
(Figure 1A). In contrast, cyclin D1+/+/MMTV-ErbB2 mice ex-
hibited accelerated mammary tumors as expected.
We next wanted to determine whether the inability of cyclin
D1KE/KE mice to develop MMTV-ErbB2-driven tumors was due
to a reduction in the number of the cellular targets for transforma-
tion. Recently, the cellular targets of MMTV-ErbB2-induced
tumorigenesis have been suggested to reside within PI-MECs
in parous animals (Boulanger et al., 2005; Henry et al., 2004;
Smith and Medina, 2008; Wagner et al., 2002) as well as within a
population of cells exhibiting a CD24+Sca1+ phenotype (Li et al.,
2007; Liu et al., 2007). Therefore, we examined the number of
CD24+Sca1+ cells as well as PI-MECs in cyclin D1KE/KE mice.
FACS analysis performed on single-cell suspensions of
mammary epithelium revealed a3-fold reduction in the number
ofCD24+Sca1+progenitor cells anda2-fold increase inCD24Low
cells present in mammary glands of cyclin D1KE/KE/MMTV-ErbB2
mice (Figure 1B). However, the fact that CD24+Sca1+ cells were
still present in cyclin D1KE/KE mice suggested that this population
might not be the cellular target for transformation.
We next assessed the number of PI-MECs in cyclin D1KE/KE
mammary glands (Smith and Medina, 2008). Accordingly, we
generated cyclin D1KE/KE/MMTV-ErbB2/WAP-cre/Rosa-GFP
mice in which the green fluorescent protein (GFP) is expressed
following pregnancy-induced Cre-mediated recombination. As
expected, the generation of GFP+ cells was confirmed during
lactation in both cyclin D1+/+ and cyclin D1KE/KE mice (Figure 1C,
upper panels). Sixweeks after postlactational involution, we con-
tinued to detect a population of GFP+ cells in parous mammary
glands of cyclin D1+/+/MMTV-ErbB2/WAP-cre/Rosa-GFP miceytometry analysis showing GFP-positive cells (PI-MECs) derived from cyclin
-ErbB2/Wap-Cre/Rosa-GFP (cyclin D1KE/KE) mammary glands 6 weeks post-
is performed onMECs derived from a parous nonpregnant cyclin D1+/+/MMTV-
erplasias). (a) shows a freshly isolated mammary gland from a parous non-
positive lesions (numbered 1 to 4) under fluorescence microscopy. The scale
ction from the same mammary gland in (a) showing that GFP-positive lesions
cale bar represents 100 mm. (c) shows a higher magnification of a hyperplastic
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Figure 2. Cyclin D1 Kinase Activity Is
Required for the Maintenance and Activity
of Progenitor Cells in the Mammary Gland
(A) Mammary glands obtained from multiparous
(three rounds of pregnancy and involution) cyclin
D1+/+ and cyclin D1KE/KE mice were morphologi-
cally analyzed 1 day postpartum. Whole mounts
and H&E-stained sections are shown. Notice the
failure to undergo normal lobuloalveolar expan-
sion observed in cyclin D1KE/KE mammary tissue.
Middle panels represent a higher magnification
of top panels. Scale bars represent 100 mm on
the top; middle, 25 mm in the middle, and 100 mm
on the bottom.
(B) Summary of dilutional transplantation experi-
ments showing that cyclin D1+/+ and cyclin D1KE/KE
MECs have similar engrafting capacity. The
number of successful transplants per total injec-
tions is indicated.
(C) Ductal outgrowths derived from transplanta-
tion of cyclin D1KE/KE MECs have normal terminal
end buds (a). The scale bar represents 100 mm.
Arrows indicate terminal end buds. As shown in
(b), cyclin D1KE/KE ductal outgrowths fail to reach
the end of the fat pad. The scale bar represents
200 mm. (c) shows decrease in the size of the
ducts derived from cyclin D1KE/KE MECs trans-
plants as seen in H&E staining. The scale bar
represents 40 mm. (d)–(f) show profound reduction
in the side branching and lobule outgrowths
derived from cyclin D1KE/KE MECs. Whole-mount
analysis (d) and H&E staining (f) are shown. Middle
panels represent a higher magnification of top
panels. Scale bars represent 100 mm in (d),
50 mm in (e), and 100 mm in (f). See also Table S1
and Figure S1.
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Cyclin D1 Regulates Mammary Progenitorsconsistent with the labeling of PI-MECs. In contrast, parous
cyclin D1KE/KE/MMTV-ErbB2/WAP-cre/Rosa-GFP mammary
tissues retained very few GFP+ cells (Figure 1C, lower panels).
The near absence of PI-MECs in cyclin D1KE/KE/MMTV-ErbB2
mice suggested that this population might contain the cell of
origin for tumorigenesis in this model. Indeed, premalignant
lesions originated in parous cyclin D1+/+/MMTV-ErbB2/WAP-
cre/Rosa-GFP mice were invariably GFP+, confirming that
they were derived from PI-MECs (Figure 1D) (Henry et al.,
2004). Collectively, these findings indicate that cyclin D1KE/KE
mice are resistant to MMTV-ErbB2-induced tumorigenesis
due to a lack of cellular targets of transformation, namely PI-
MECs.
Cyclin D1 Activity Is Required for Mammary Progenitor
Cell Self-Renewal and Activity
The fact that virtually no PI-MECs were detectable in parous cy-
clin D1KE/KE mammary glands suggested a failure of this popula-
tion to self-renew and, therefore, to be maintained following
pregnancy. Consequently, we speculated that these mice might
exhibit defects in the ability to form lobuloalveoli following
successive cycles of pregnancy-induced proliferation and differ-
entiation. Indeed, mammary tissues from cyclin D1KE/KE mice
showed a pronounced failure to undergo full lobuloalveolar68 Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc.differentiation after a third pregnancy (Figure 2A). This observa-
tion combined with the inability to maintain PI-MECs indicates
that cyclin D1-associated kinase activity is necessary for the
maintenance of progenitor cells.
To determine the extent to which other progenitor cell activi-
ties might also be compromised in the absence of cyclin D1
kinase activity, we examined the regenerative capacity of
MECs isolated from mutant and wild-type mice following trans-
plantation into cleared fat pads. Bipotent stem cells give rise to
two types of progenitor cells that mediate regenerative activities:
ductal progenitors that give rise to cap cells and drive ductal
elongation through the terminal end bud structure, and the lobule
progenitors that produce the progeny for the side branches and
lobular-alveolar development (Smith and Medina, 2008). Single-
cell suspensions of cyclin D1KE/KE or cyclin D1+/+ MECs were
transplanted into contralateral cleared fat pads in a dilution
series ranging from 50,000 to 2,000 cells. Both cyclin D1+/+
and cyclin D1KE/KE MECs exhibited comparable engraftment
rates at limiting dilutions and formed terminal end buds at the
growing tips of the penetrating ducts 5 weeks after transplanta-
tion (Figures 2B and 2C, a). However, nearly 75% of all the
outgrowths derived from cyclin D1KE/KE MECs failed to fill the
entire fat pads while this only occurred in 35% of the transplants
from cyclin D1+/+ cells (Figures 2C, b; see also Table S1 available
Figure 3. Lack of Cyclin D1 Kinase Activity
Leads to Decreased Self-Renewal of
Mammary Progenitors and a Reduction in
the CD24HiCD49fLow Population
(A) The left panels show sphere formation assays
for cyclin D1+/+ and cyclin D1KE/KE MECs plated
in low-attachment plates and serum-free condi-
tions (see Experimental Procedures). Quantifica-
tion of the number of primary and secondary
spheres per 5 cm2 and the size of secondarymam-
mospheres (in mm) is shown. There was no signif-
icant difference in the number of primary spheres
formed by cyclin D1+/+ and cyclin D1KE/KE MECs
(p = 0.236). The number of secondary spheres,
however, was significantly reduced in the context
of KE mutation (p < 0.05). The size of secondary
spheres was similar between genotypes. Error
bars indicate mean ± SD; *p < 0.05. As shown in
the right panels, secondary spheres derived from
cyclin D1+/+ and cyclin D1KE/KE MECs (a and b)
were dissociated on day 21 and embedded in Ma-
trigel (c and d). The resulting acinar structures
were stained for DAPI (blue), smooth muscle actin
(green) and E-cadherin (red) and analyzed by
confocal microscopy (e and f). Scale bars repre-
sent 50 mm in (a)–(d) and 10 mm in (e) and (f).
(B) Flow cytometry analysis showing the distribu-
tion of Lin() MECs for the expression of the
surface markers CD24 and CD49f. Notice the
decrease in the CD24HiCD49fLow and the increase
in the CD24MedCD49fHi cell fractions in cyclin
D1KE/KE MECs compared with cyclin D1+/+
MECs. Error bars indicate mean ± SD; *p < 0.01.
(C) As shown in the left panels: Crystal violet stain-
ing of epithelial colonies formed on a feeder layer
of growth-arrested fibroblasts (see Experimental
Procedures). Quantification of the number of
colonies per 10x field is shown. Notice the reduc-
tion in the number of colonies generated by cyclin
D1KE/KE MECs. Error bars indicate mean ± SD;
*p < 0.001. As shown in the right panels: Three
distinct types of colonies (luminal, myoepithelial,
and mixed) were identified based on both
morphology (a) and immunostaining (b and c).
A quantification of the proportions of the different
types of colonies derived from cyclin D1+/+ and cy-
clin D1KE/KEMECs is shown. SMA, smoothmuscle
actin; E-cad, E-cadherin; CK18, cytokeratin 18.
Scale bars represent 20 mm in (a) and 50 mm in
(b) and (c). See also Figure S2.
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Cyclin D1 Regulates Mammary Progenitorsonline). In addition, there was a reduction in the overall number of
ducts as well as a decrease in ductal size of mammary trees
derived from cyclin D1KE/KE MECs (Figure 2C, b and c). Impor-
tantly, the ductal system derived from cyclin D1KE/KE MECs
was nearly devoid of all side branching and lobules (Figure 2C,
d–f, and Figure S1). This observation was independent of the
number of cells transplanted or the estrus status of the recipient
mice at the time of sacrifice (see Experimental Procedures). This
finding indicates that mammary progenitor cell self-renewal is
compromised in the absence of cyclin D1-associated kinase
activity.
To further assess the defect in self-renewal activity, we exam-
ined the ability of cyclin D1KE/KE and cyclin D1+/+ MECs to form
spheres under nonadherent and serum free conditions (Dontuet al., 2003). We found that cyclin D1+/+ and cyclin D1KE/KE
MECs formed similar numbers of primary spheres (45 ± 15.9
versus 36.7 ± 8.7 for wild-type and KE, respectively, p = 0.236;
Figure 3A, left panels). However, secondary sphere formation
was reduced 2-fold in cyclin D1KE/KE MECs compared with
cyclin D1+/+ MECs (18.0 ± 1.0 versus 36.7 ± 7.1 for KE and
wild-type cells, respectively, p = 0.0212; Figure 3A, left panels)
suggesting that the self-renewal capacity of progenitors was
impaired in the absence of cyclin D1-associated kinase activity.
We failed to observe any differences in the size of spheres
between genotypes (Figure 3A left panels, and Figure 3A,
a and b). Taken together, these data indicate that cyclin D1
activity is necessary for the regeneration of mammary tissues
and the self-renewal of mammary progenitor cells.Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc. 69
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Cyclin D1 Regulates Mammary ProgenitorsWe also examined colony formation of sphere-derived cells in
Matrigel. Colonies generated from mutant spheres grew as
spherical acinar structures that were smaller in size compared
with those derived from cyclin D1+/+ spheres (Figure 3A, c and
d). In addition, confocal immunofluorescence microscopy anal-
ysis revealed that cyclin D1KE/KE acini were composed of an
outer layer of SMA+ myoepithelial cells and an inner layer of
luminal cells that failed to express E-cadherin (Figure 3A, e and
f). This suggested that colony forming progenitor cells from cy-
clin D1KE/KE mammary glands lack full bipotent activity
compared with those derived from cyclin D1+/+mammary glands
(see below). Taken together, these data indicate that cyclin D1
activity is necessary for regeneration of mammary tissues and
for the self-renewal and differentiation of mammary progenitor
cells.
Mammary Tissues Lacking Cyclin D1 Activity Have
Reduced Bipotent CD24HiCD49fLow Cells
Because PI-MEC progenitors cannot bemaintained inmammary
glands of mice lacking cyclin D1 kinase activity, we reasoned
that we could identify this population of cells by fluorescence-
activated cell sorting (FACS) because it should be absent or
greatly reduced in virgin cyclin D1KE/KE mice. Stem/progenitor
cells with regenerative activity following transplantation into
cleared fat pads can be enriched in either CD24MedCD29Hi or
CD24MedCD49fHi populations (Matulka et al., 2007; Shackleton
et al., 2006; Stingl et al., 2006). Therefore, we first examined
the distribution of CD24 and CD29 markers in cyclin D1KE/KE
and cyclin D1+/+ MEC preparations that were gated for CD45(-)
cells. We found no significant difference in the number of
CD24MedCD29Hi cells in cyclin D1KE/KE mammary glands com-
pared with cyclin D1+/+ tissues, suggesting that this population
of progenitors was not affected by cyclin D1 activity (Figure S2A).
We next analyzed Lin() MECs from cyclin D1KE/KE mice using
the cell surface markers CD24 and CD49f. Consistent with
previous reports (Stingl et al., 2006), we identified two popula-
tions of cells in cyclin D1+/+ as well as cyclin D1KE/KE mammary
glands (Figure 3B). Noncommitted progenitor cells are reported
to reside within both CD24MedCD49fHi and CD24HiCD49fLow
populations. CD24MedCD49fHi cells enrich for mammary recon-
stitution units that can regenerate an entire mammary tissue
following transplantation, whereas CD24HiCD49fLow cells enrich
for colony-forming cells that can form heterogeneous colonies
when plated in vitro (Stingl et al., 2006). Despite the reduced
regenerative potential of cyclin D1KE/KE MECs, we found that
mammary glands lacking cyclin D1 kinase activity contained
increased numbers of CD24MedCD49fHi cells but a significant
decrease in CD24HiCD49fLow cells (Figure 3B).
Because cells with the ability to form adherent colonies in vitro
are enriched within the CD24HiCD49fLow fraction (Stingl et al.,
2001), and this population was reduced in cyclin D1KE/KE
mammary tissues, we reasoned that the colony-forming
capacity of cyclin D1KE/KE MECs should be impaired. Indeed,
we found that cyclin D1KE/KE MECs displayed decreased
colony-forming potential compared with cyclin D1+/+ MECs
(Figure 3C, left panels). When primary MECs are assayed in this
way, they form three distinct luminal, myoepithelial, and mixed
colonies, derived from luminal, myoepithelial, and bipotent
progenitors, respectively (Stingl et al., 2001). Luminal colonies70 Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc.consist of tightly arranged cuboidal cells, whereas pure myoepi-
thelial colonies have dispersed, teardrop-shaped cells. Mixed
colonies are composed of a central core of tightly arranged cells
surrounded by more dispersed cells. We observed that both
cyclin D1KE/KE and cyclin D1+/+ MECs were able to form all three
types of colonies as confirmed by staining for alpha-smooth
muscle actin (SMA), E-cadherin, and cytokeratin 18 (CK18)
(Figure 3C, a-c). However, cyclin D1KE/KE MECs formed fewer
luminal colonies aswell as greater numbersofmyoepithelial colo-
nies compared with MECs derived from cyclin D1+/+ mammary
tissues (Figure 3C, right panels). Consistent with this shift in cell
fate in D1KE/KEMECs, we observed that cyclin D1was expressed
almost exclusively in luminal epithelial cells, but not inmyoepithe-
lial cells in these colonies (Figure S2B). These findings suggested
that colony-forming progenitor cells from cyclin D1KE/KE
mammary glands lack full bipotent activity compared with those
from cyclin D1+/+ mammary glands.
Mammary Tissues Contain Distinct Progenitor Cell
Populations
The fact that cyclin D1KE/KE MECs are defective in progenitor
cells with the ability to self-renew yet exhibit an increase in
CD24MedCD49fHi cells would seem conceptually inconsistent
with the current mammary stem/progenitor cell model. There-
fore, we first needed to exclude the possibility that
CD24MedCD49fHi cells might require cyclin D1 activity for proper
function and differentiation. Accordingly, we examined the differ-
entiation potential of sorted CD24HiCD49fLow and
CD24MedCD49fHi cells from cyclin D1KE/KE and cyclin D1+/+
mammary tissues. Progenitor cells within the CD24HiCD49fLow
population form spherical acinar structures, whereas
CD24MedCD49fHi cells form solid, irregular-shaped colonies
when embedded in Matrigel (Stingl et al., 2006). Indeed, wild-
type CD24HiCD49fLow cells formed predominantly hollow spher-
ical colonies, whereas CD24MedCD49fHi cells formed predomi-
nantly solid spheres (Figure 4A). Importantly, we found that
sorted CD24HiCD49fLowcells from cyclin D1KE/KE mice displayed
a marked decrease in the formation of large hollow acini
compared with those derived from wild-type controls while the
number and size of CD24MedCD49fHi- derived colonies was
indistinguishable between genotypes (Figure 4A and data not
shown). In addition, we also examined the differentiation poten-
tial of Matrigel colonies for the presence of myoepithelial
markers (cytokeratin 14 and SMA) and luminal epithelial markers
(cytokeratin 18 and E-cadherin). CD24MedCD49fHi MECs from
cyclin D1+/+ and cyclin D1KE/KE mammary tissues gave rise to
similar numbers of colonies expressing the myoepithelial
markers SMA or cytokeratin 14, or the luminal epithelial markers
cytokeratin 18 or E-cadherin (Figure 4B, Figure S3A, and data
not shown). However, sorted CD24HiCD49fLow cells from cyclin
D1KE/KE tissues gave rise to a higher proportion of colonies
containing SMA+ cells (Figure 4B) compared with sorted
CD24HiCD49fLow cells from cyclin D1+/+ glands, suggesting
a defect in the differentiation potential of this population in the
absence of cyclin D1 kinase activity. To further confirm our find-
ings, we assessed the mRNA expression levels of CD61, a re-
ported marker for luminal progenitor cells (Asselin-Labat et al.,
2007), in CD24/CD49f-sorted populations. We observed a signif-
icant 2-fold decrease in CD61 expression in CD24HiCD49fLow
Figure 4. Mammary Tissues Lacking Cyclin
D1 Kinase Activity Have Reduced Bipotent
CD24HiCD49fLow Cells
(A) CD24HiCD49fLow and CD24MedCD49fHi popu-
lations derived fromcyclinD1+/+ andcyclinD1KE/KE
MECs were embedded in Matrigel (Debnath et al.,
2003) and the type and number of colonies formed
was microscopically assessed 10 days later. As
expected, CD24HiCD49fLow cells derived from cy-
clin D1+/+ MECs gave rise to large lumen-contain-
ing structures (acini). However, the number of acini
formed by CD24HiCD49fLow cells was dramatically
reduced in the context of cyclin D1 kinase activity
deficiency. No significant difference was in the
number and size of solid colonies generated from
CD24MedCD49fHi populations of either genotype.
Insets showDAPI-stained representative colonies.
The scale bar represents 50 mm.Error bars indicate
mean ± SD; *p < 0.01.
(B) Colonies generated in (A) were subjected to
immunofluorescence for the detection of myoepi-
thelial (SMA) and luminal epithelial cell (K18)
markers. Most acini generated from wild-type
CD24HiCD49fLow cells were negative for SMA.
However, 12% of them showed the presence of
SMA-positive cells. This proportion was increased
to 30% in colonies generated from mutant
CD24HiCD49fLow cells. On the other hand,
most structures generated from CD24MedCD49fHi
cells were strongly positive for SMA (>90%), with
20% of them showing strong K18 costaining.
No differences in staining between genotypes
were observed in this fraction of cells. SMA,
smooth muscle actin; K18, keratin-18. The scale
bar represents 50 mm. Error bars indicate mean ±
SD; *p < 0.001. See also Figures S3A and S3B.
(C) The upper panels show whole mounts of
outgrowths derived from sorted CD24MedCD49fHi
and CD24HiCD49fLow populations purified from
wild-type nulliparous mice. A total of 5 3 104
CD24MedCD49fHi or 53 104 CD24HiCD49fLow cells
were injected into cleared fat pads of virgin Balb/c
female mice. Representative ductal trees illustrate
the duct-only derived growths from sorted
CD24MedCD49fHi cells while CD24HiCD49fLow cells
gave rise to ducts and lobules under the same
conditions. Arrows: lobule side branches. The
lower panels show lobular/alveolar outgrowths
derived from sorted CD24MedCD49fHi and
CD24HiCD49fLow cells transplanted into cleared
fat pads of pregnant hosts. A total of 5 3 104
CD24MedCD49fHi or 53 104 CD24HiCD49fLow cells
were injected into cleared fat pads of pregnant
Balb/c female mice. Representative whole mounts of ductal/alveolar trees illustrating the lobular/alveolar growths derived from sorted CD24MedCD49fHi and
CD24HiCD49fLow cells are shown. Note that CD24HiCD49fLow cells also produced lobule-only and acinar-only growths in pregnant hosts. Scale bars represent
500 mm. See also Figure S3C.
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Cyclin D1 Regulates Mammary ProgenitorsMECs derived from cyclin D1KE/KE mammary glands compared
with the same population derived from wild-type MECs
(Figure S3B). However, there was no significant difference in
CD61 expression between CD24MedCD49fHi fractions from
cyclin D1KE/KE and cyclin D1+/+ MECs (Figure S3B). Although
these findings demonstrate that CD24MedCD49fHi as well as
CD24HiCD49fLow populations both contain bipotent progenitor
cells, only CD24HiCD49fLow cells exhibit defects in differentiation
potential in the absence of cyclin D1 kinase activity.Our findings suggest that a proportion of CD24HiCD49fLow
cells contain bipotential progenitor activity, and this activity is
impaired in the absence of cyclin D1 kinase activity. We therefore
assessed the in vivo reconstitution activity of sorted
CD24MedCD49fHi and CD24HiCD49fLow cells (5 3 104) derived
from wild-type mammary glands following transplantation into
cleared mammary fat pads of either nulliparous (virgin) or preg-
nant hosts (Figure 4C). Consistent with previous studies, we
found that sorted CD24MedCD49fHi cells were indeed capable ofCancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc. 71
Figure 5. Defects in Luminal-Lineage
Differentiation in the Absence of Cyclin D1
Kinase Activity
(A) Immunofluorescence and immunohistochem-
ical analysis of innate mammary glands derived
from cyclin D1+/+ and cyclin D1KE/KE mice. Cos-
tainings for SMA (green) and CK18 (red) and
stainings for estrogen receptor alpha (ER) are
shown. Notice the reduced CK18 staining in cyclin
D1KE/KE tissue compared with its cyclin D1+/+
counterpart. No difference in ER staining was
observed. SMA, smooth muscle actin; CK18, cy-
tokeratin-18; ER, estrogen receptor. The scale
bar represents 40 mm.
(B) Immunofluorescence staining of ducts derived
from transplants of cyclin D1+/+ and cyclin D1KE/KE
MECs for the myoepithelial marker SMA (green)
and luminal markers E-cadherin or CK18 (red).
SMA, smooth muscle actin; CK18, cytokeratin-
18; E-Cad, E-cadherin. The scale bar represents
40 mm. See also Figure S4A.
(C) As shown in the upper panels, cyclin D1+/+ and
cyclin D1KE/KE MECs were analyzed by flow cy-
tometry for the expression of the surface marker
CD24. There was an increase in the CD24Low pop-
ulation (CD24L) and a reduction in theCD24Hi pop-
ulation (CD24H) in cyclin D1KE/KE MECs (KE)
compared with cyclin D1+/+ MECs (WT). The
CD24H: CD24L ratio for each genotype is also
shown. *p < 0.05. As shown in the lower panels,
CD24-sorted cells were cytospun directly on glass
slides and subsequently stained by for SMA and
E-cadherin. As expected, the majority of CD24Hi
cells (CD24H) were E-cadherin positive and SMA
negative and the opposite was observed for
CD24Low populations (CD24L). SMA, smooth
muscle actin; E-Cad, E-cadherin. Error bars indi-
cate mean ± SD. See also Figure S4B.
(D) Gene expression analysis of CD24Hi popula-
tions for CK18, CK6, and GATA3 by quantitative
RT-PCR. Error bars indicate mean ± SD; *p < 0.01.
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Cyclin D1 Regulates Mammary Progenitorsductal and lobular/alveolar development when transplanted into
cleared fat pads of pregnant hosts, indicating that cells within
this population have the capacity to undergo full lobuloalveolar
differentiation under pregnancy-induced conditions (Stingl et al.,
2006). However, we found that the ductal trees derived from
CD24MedCD49fHiMECs injected intonulliparoushostswerenearly
devoid of all side branching and lobule development, indicating
that CD24MedCD49fHi cells were unable to give rise to lobular/
alveolar development in the absence of pregnancy (Figure 4C).
Moreover, we found that injection of CD24HiCD49fLow cells not
only generated ductal and lobular/alveolar outgrowths in preg-
nant hosts but also lobule-only and alveolar-only outgrowths
(Figure 4C). Furthermore, we found that sorted CD24HiCD49fLow
cells produced ductal and lobular development with extensive
side branching in nulliparous hosts, indicating that bipotent
progenitor cells reside within this fraction and that these cells
do not depend on the hormones of pregnancy for their differen-
tiation potential (Figure 4C). It is worth noting that while
CD24MedCD49fHi and CD24HiCD49fLow cells resulted in compa-
rable engraftment rates and fat-pad filling in the nulliparous host,
sorted CD24MedCD49fHi cells did exhibit a slight increase in72 Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc.fat-pad filling in pregnant hosts, consistent with the notion that
CD24MedCD49fHi cells enrich for cells with greater mammary re-
constituting activity in pregnant mice (Figure S3C) (Stingl et al.,
2006).
Defects in Luminal-Lineage Differentiation in the
Absence of Cyclin D1 Kinase Activity
The data described above demonstrate a cyclin D1-activity
dependence for the formation of lobular-alveolar structures,
and also indicate that the ratio of luminal and myoepithelial cells
is altered in cyclin D1KE/KE animals. To further explore this defect
in epithelial differentiation, we stained cyclin D1KE/KE or cyclin
D1+/+ mammary tissues for markers of luminal (K18) and myoe-
pithelial (SMA) differentiation. We found that myoepithelial cells
within the main ducts of cyclin D1KE/KE and cyclin D1+/+
mammary glands expressed SMA, but luminal cells in cyclin
D1KE/KE glands lacked a robust K18 expression compared with
cyclin D1+/+ ducts (Figure 5A). In addition, although some reports
suggest that keratin-6 (K6) is a marker of mammary progenitor
cells, others have shown it to be abundantly expressed in differ-
entiated luminal alveolar cells (Li et al., 2003; Smith et al., 1990).
Figure 6. The Role of Cyclin D1 in the
Mammary Epithelial Hierarchy
A proposed model of the mammary epithelial cell
developmental hierarchy in which cyclin D1
expression and activity are required for the main-
tenance of the lobule progenitors, which are
synonymous with the PI-MEC population.
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Cyclin D1 Regulates Mammary ProgenitorsWe found no K6-positive cells in cyclin D1KE/KE mammary
tissues (data not shown). However, not all luminal markers
were misexpressed, given that the expression of estrogen
(ERa) and progesterone receptors (PR-A and PR-B) was similar
in luminal cells from both cyclin D1KE/KE and cyclin D1+/+ glands
(Figure 5A and data not shown). These data indicate that despite
normal histological appearance, mammary ducts in cyclin
D1KE/KE mice exhibit altered luminal cell differentiation.
Given these findings, we next examined ductal outgrowths
from cyclin D1+/+ and cyclin D1KE/KE transplants for evidence
of perturbed luminal epithelial differentiation. Indeed, luminal
cells of cyclin D1KE/KE ductal outgrowths did not express abun-
dant E-cadherin and were negative for keratin-18 expression
(Figure 5B). Furthermore, while K6 positive cells were found in
the transplantation outgrowths derived from the cyclin D1+/+
MECs, no K6 expression was detected in cyclin D1KE/KE
outgrowths (Figure S4A). K6-positive cells in wild-type ducts
were localized to the inner layer of the ductal epithelium, were
negative for SMA, and coexpressed GATA-3, the luminal marker
and transcription factor required for luminal differentiation (Asse-
lin-Labat et al., 2007; Kouros-Mehr et al., 2006). However, ductal
outgrowths from cyclin D1+/+ and cyclin D1KE/KE MECs both dis-
played a prominent outer layer of SMA-positive myoepithelial
cells, indicating that this lineage was not perturbed.
To further evaluate the defects in luminal cell differentiation,
we analyzed dispersed single-cell suspensions from cyclinCancer Cell 17, 65–76D1+/+ and cyclin D1KE/KE mammary
tissues sorted by FACS. Differential stain-
ing of mammary epithelial cells on the
basis of CD24 expression can discrimi-
nate between different lineages of
mammary epithelial cells (Sleeman
et al., 2006; Sleeman et al., 2007). Myoe-
pithelial and luminal epithelial cells are
identified as CD24Low and CD24Hi,
respectively, while CD24-negative cells
are considered to be nonepithelial cells.
Using this approach, we found a signifi-
cant increase in the percentage of
CD24Low (CD24L) cells and a significant
reduction in the percentage of CD24Hi
(CD24H) cells in cyclin D1KE/KE MECs
(Figure 5C, upper panels). To confirm
that the disproportionate percentage of
CD24L cells in cyclin D1KE/KE glands
were myoepithelial cells, sorted CD24Low
and CD24Hi cells were directly cytospun
on glass slides and stained for SMA and
E-cadherin. As expected, most of the
CD24L cells stained positive for SMAand negative for E-cadherin, while the majority of CD24H cells
were E-cadherin positive and SMA negative (Figure 5C, lower
panels, and Figure S4B). Next, gene expression patterns of
CD24Hi cells were examined using quantitative real-time poly-
merase chain reaction (RT-PCR). We found that CD24Hi luminal
cells derived from cyclin D1KE/KE glands exhibit a reduction of
CK18, GATA-3, and CK6 expression compared with cyclin
D1+/+ cells, confirming that luminal cells exhibited altered differ-
entiation in the absence of cyclin D1 kinase activity (Figure 5D).
These findings imply that in the absence of cyclin D1-dependent
kinase activity, differentiation of luminal cells is impaired and is
accompanied by an accumulation of myoepithelial cells.
DISCUSSION
Our results, combined with those of others (Smith, 1996; Smith
andMedina, 2008), support a more complex model of mammary
gland hierarchy and differentiation. Multipotent CD24+CD49f+
stem cells (PI-MECs) give rise to lineage-committed lobule
progenitor cells (also termed PI-MECs in parous mice) and
ductal progenitor cells, both of which have the capacity to give
rise to luminal and myoepithelial cells, but exhibit different func-
tional outgrowth potential (Figure 6). We found that PI-MECs
require cyclin D1 kinase activity for their self-renewal because
ductal and lobule outgrowth potential were significantly impaired
following transplantation into clear fat pads. In addition, in, January 19, 2010 ª2010 Elsevier Inc. 73
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epithelial cell differentiation and tissue regeneration after serial
rounds of pregnancy/lactation was also impaired. These data
indicate that maintenance of PI-MECs and their progeny is
necessary for long-term mammary tissue homeostasis and
differentiation. Moreover, these data are consistent with
previous reports, which have demonstrated that PI-MECs
contain bothmultipotent stem cells that self-renew and generate
diverse epithelial lineages of the murine mammary gland as well
as lobule-committed progenitors (Boulanger et al., 2005; Henry
et al., 2004; Smith and Medina, 2008; Wagner et al., 2002).
PI-MECs have also been reported to express both CD24 and
CD49f surface markers (Boulanger et al., 2005; Henry et al.,
2004; Smith and Medina, 2008; Wagner et al., 2002). Consistent
with this notion, we observed that both CD24HiCD49fLow and
CD24MedCD49fHi cells could regenerate complex mammary
trees composed of ducts, lobules, and alveoli when transplanted
into pregnant hosts. Remarkably, we found that while
CD24HiCD49fLow cells produced complex mammary outgrowths
when implanted into cleared fat pads of nulliparous hosts,
CD24MedCD49fHi cells failed to develop ductal structures
that contained side branches or lobules. This suggests that
multipotent stem cells are a minority subpopulation within
CD24MedCD49fHi cells that are only stimulated in the presence
of pregnancy hormones. Therefore, it will be of great interest to
identify additional markers beyond CD24 and CD49f that can
further distinguish between multipotent stem cells and lineage-
committed progenitor cells.
It is worth noting that our findings are not inconsistent with
previous reports, but rather extend the mammary hierarchy to
incorporate the different functional lineages and anatomical
structures that make up breast tissue. It is also worth noting
that the transplant experiments described in this studywere con-
ducted in the presence ofMatrigel. We did find that in vivo recon-
stitution activity of sorted CD24HiCD49fLow cells was greatly
compromised in the absence of Matrigel (data not shown).
Consistent with this notion, coinjection with Matrigel in other
stem cell assays has been reported to enhance engraftment of
primary epithelial cells (Quintana et al., 2008). Consequently,
the observations we have reported herein provide strong
evidence that modification of the transplantation assay can
enable the detection of progenitor cell activity and regeneration
potential of mouse mammary epithelial cells. This has provided
for a means to identify additional stem/progenitor cell popula-
tions that appear to have diverse functional activities and exhibit
unique sensitivity to pregnancy hormones.
In addition to expanding the mammary gland hierarchy, our
data demonstrate that: (1) cyclin D1 activity is required for the
maintenance of PI-MECs and lobule progenitor cells; (2) PI-
MECs are the target of MMTV-ErbB2-mediated tumorigenesis;
and (3) the inability to maintain PI-MECs and lobule progenitor
cells results in mammary tissues with a disproportionate number
of myoepithelial cells and impaired state of differentiation of
luminal epithelial cells.
Our data can also explain the described differential suscepti-
bility of cyclin D1 knockout mice to different mammary onco-
genes (Yu et al., 2001). Accordingly, MMTV-Wnt1- and MMTV-
Myc-driven tumors are likely to arise from ductal progenitor
cells, whereas MMTV-Ras and MMTV-ErbB2 tumors arise from74 Cancer Cell 17, 65–76, January 19, 2010 ª2010 Elsevier Inc.lobule progenitor cells (Chepko et al., 2005; Shackleton et al.,
2006). Recently, CD29HiCD24Med cells were found to expand in
early hyperplastic lesions of MMTV-Wnt1 mammary glands but
not in those transformed by MMTV-ErbB2 (Shackleton et al.,
2006). It was proposed that this population of progenitor cells
is likely to be the cellular origin of MMTV-Wnt1-driven trans-
formation but not that of MMTV-ErbB2. As shown in our model
(Figure 6), cyclin D1 kinase activity is required for the mainte-
nance of lobule progenitors, the tumor-initiating cells of
MMTV-ErbB2- and MMTV-Ras-mediated tumorigenesis, but is
not required for the maintenance of the ductal progenitors, the
tumor-initiating cells of MMTV-Wnt1 and MMTV-Myc. In fact,
we saw an increase in the CD24MedCD49fHi population that
contains ductal progenitors in mammary glands lacking cyclin
D1 activity, suggesting that loss of cyclin D1 could actually
increase Wnt1- or Myc-induced tumorigenesis. In support of
this possibility, cyclin D1 knockout mice that constitutively
express beta-catenin in the mammary gland have an increased
frequency and decreased latency for tumor development
compared with MMTV-Wnt1 tumorigenesis (Rowlands et al.,
2003).
Our initial finding that during a first pregnancy the cyclin
D1KE/KE MECs are able to expand their lobuloalveolar units
similar to those of cyclin D1+/+ MECs made it difficult to dissect
the role of cyclin D1 as a regulator of development from that
important for transformation. However, after successive preg-
nancies we observed a significant reduction in lobuloalveoli
development similar to, but not as profound as, the reduction
seen the cyclin D1 knockout mouse after a first pregnancy. This
delay in the developmental phenotype relative to that seen in
the cyclin D1 knockout animals may indicate that a noncatalytic
function of cyclin D1/Cdk complexes, such as titration of the
cell-cycle inhibitors p27Kip1 and p21Cip1, may be sufficient for
the expansion of the ductal progenitors but only weakly able to
influence lobule progenitor cell proliferation. The identity of the
critical targets of these catalytic and noncatalytic functions of cy-
clin D1 in the mammary epithelium remains to be determined.
Although not as well studied, there is evidence to support the
existence of a mammary epithelial hierarchy with bipotent
progenitors in the human breast (Stingl et al., 2001). Recently
a unique population of cells that could be the human lobule
progenitor has been identified. These cells are EpCamHiCD49f+
(resembling the CD24HiCD49f+ population in mice), exhibit
increased colony-forming ability, and can give rise to both
luminal and myoepithelial cells (Villadsen et al., 2007). Studying
the effects of loss of cyclin D1 or CDK4 on this population could
potentially help us to understand the role of cyclin D1 in the
human breast as well as further delineate the human mammary
epithelial hierarchy.
Lastly, this study reiterates the importance of tailoring the
treatment in breast cancer aswell as other cancers to the biology
of the tumor. As we show here, cyclin D1-associated kinase
activity is critical for the maintenance of the cells driving
MMTV-ErbB2 tumors as well as other luminal tumors, but not
for the cells driving tumors originating from ductal progenitor
cells. Our studies support the notion that treatments targeting
cyclin D1 will be effective for the prevention and treatment of
luminal type cancers but will most likely not be effective, and
may even be deleterious, in patients with basal-type cancers.
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Mouse Strains
The generation of cyclin D1KE/KE mice was described previously (Landis et al.,
2006). The MMTV–ErbB2 mouse (strain TG.NK) used in this study has been
described elsewhere (Muller et al., 1988). ROSA26-GFPmice were purchased
from the Jackson Laboratories.WAP-cre transgenic mice were obtained from
the NCI Mouse Models of Human Cancers Consortium. All animals used were
treated humanely and in accordance with protocols approved by the Institu-
tional Animal Care and Use Committee at Tufts Medical Center.
Preparation of Single-Cell Suspensions
Mammary glands were harvested from 12-week-old mice (except for PI-MECs
studies in which mice were sacrificed 6 weeks postinvolution). Glands were
mechanically disaggregated and then digested with collagenase (Sigma) and
Hyaluronidase (Sigma) for 3–6 hr at 37C. The resultant organoids were further
digested in 0.25% trypsin-EDTA (2 min) and Dispase/DNaseI (5 min), and then
filtered through a 40 mmmesh.When necessary, Lin+ cells (CD45+, CD31+, and
Ter 119+) were immunomagnetically removed from freshly isolated cells using
theEasysepmousemammarystemcell enrichmentkit (StemCell Technologies).
Mammary Fat-Pad Transplants
For limiting dilution experiments, freshly isolated MECs were resuspended in
40 ml phosphate-buffered saline (PBS) and injected into cleared inguinal fat
pads of 3-week-old nonobese diabetic/severe combined immunodeficient
mice (Deome et al., 1959). Cyclin D1KE/KE or cyclin D1+/+ MECs were trans-
planted into contralateral inguinal fat pads. Five weeks after transplantation
glands were harvested and processed for whole mounting. Freshly sorted
CD24HiCD49fLow and CD24MedCD49fHi cells purified from Balb/c mammary
glands were resuspended in 25 ml Matrigel:Medium (1:3) solution and injected
into cleared inguinal fat pads of syngeneic Balb/c female mice. For nulliparous
studies, 3-week-old Balb/c females were used as hosts. For pregnant hosts,
3-week-old Balb/c female mice were cleared of their endogenous epithelium
and allowed to mature for 5 weeks. At 8 weeks, mice were mated and exam-
ined daily for positive plugs. Mice that were negative for plugs were used as
age-matched nulliparous controls. Pregnant and nonpregnant control hosts
were injected with sorted cells, and 3 weeks after transplantation glands
were harvested and processed for whole mounting. Before being sacrificed,
the stage at the estrous cycle of each recipient mouse was determined by
microscopic inspection of hematoxylin-stained vaginal smears. Transplanta-
tions were considered negative if there were no epithelial outgrowths, and
positive if the outgrowth appeared to originate from a central location and
branch out in multiple directions. If the outgrowth appeared to originate from
the side of the gland and the branching was mainly unidirectional, the trans-
plant was considered as a failed clearance. Percent filling was quantified under
a dissecting microscope at 2X magnification using the following formula:
% filling = length of ductal outgrowth/ total length of mammary fat pad.
Whole Mounts
Mammary glands were spread onto glass slides and fixed in glacial acetic
acid:ethanol (1:3), hydrated, and stained overnight in 0.2% carmine red.
Glands were subsequently dehydrated with graded ethanol solutions, cleared
in toluene and mounted.
Immunostaining
Tissue sections were incubated overnight at 4C with primary antibodies
diluted in 2% bovine serum albumin PBS. Secondary antibodies were applied
for 1 hr at room temperature. Sections were counterstained with DAPI when-
ever necessary. For cells cytospun directly onto glass slides, fixation was
carried out in methanol:acetone (1:1) at 20C for 10 min. A Nikon Eclipse
80t microscope and SPOT camera were used for analyzing and photographing
the stained sections. The antibodies used included SMA (Neomarkers),
E-cadherin (Santa Cruz biotechnologies), CK18 (Abcam), K6 (Covance),
GATA-3 (Santa Cruz Biotechnologies), and ERa (Dako).
Flow Cytometry
Freshly isolated Lin() cells (CD45, CD31, and Ter119) were incubated
with primary antibodies according to the manufacturer’s instructions (StemCell Technology). Antibodies used were CD29 (Chemicon), CD24 and CD49f
(StemCell Technology), CD45 (Caltag), and SCA-1 (BD PharMingen). Cell sort-
ing was carried out with a modular flow cytometer (Beckman-Coulter) and
analysis was done with FlowJo.
In Vitro Assays
Freshly isolated MECs (53 104) were seeded on 10 cm plates containing sub-
confluent, gamma-irradiated NIH 3T3 cells (5 Gy) as feeder layers. On day 5,
mammary colonies were fixed with methanol, stained with crystal violet, and
counted. For sphere-formation assays, freshly isolated MECs (20,000 cells
per 3 ml) were plated on nonadherent plates (Corning) in serum-free medium.
Primary spheres were dissociated with trypsin after 3 weeks and filtered
through a 40 mM mesh. Single cells were plated again in nonadherent plates
for secondary spheres formation. When necessary, secondary spheres were
also dissociated and single cells embedded in Matrigel (BD Biosciences) as
described elsewhere (Debnath et al., 2003). The resultant acini were fixed
with 2% PFA on day 7 and stained as described previously (Debnath et al.,
2003). Images were captured with a Leica TCS SP2 confocal microscope.
Quantitative RT-PCR
Total RNA from sorted cells was extracted with the RNeasy Mini Kit (QIAGEN).
cDNA was prepared with an iScript kit (Bio-Rad) and PCR was carried out with
SYBR Green (QIAGEN). The following primers were used in this study: CK18
forward 50-CTTGCTGGAGGATGGAGAAG-30 and CK18 reverse 50-CTGG
CTGGAGCAGGAGATTCG-30; GATA-3 forward 50-AGCCACATCTCTCCCTT
CAG-30 and GATA-3 reverse 50-AGGGCTCTGCCTCTCTAACC-30; CK6
forward 50-AGAGAGGGGTCGCATGAACT-30 and CK6 reverse 50-TCATCTGT
TAGACTGTCTGCCTT-30; CD61 forward 50-CCACACGAGGGGTGAACT-30
and CD61 reverse 50-CTTCAGGTTACATGGGGGTGA-30. Samples were run
on an Opticon2 detection system (MJ research). GAPDH was used as an
internal control. Analysis was performed with the delta-delta ct method with
the comparator being RNA extracted from wild-type unsorted cells.
Statistical Analysis
p values were determined with a two-tailed distribution and two-sample
unequal variance Student’s t test.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.ccr.2009.11.024.
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